Dermatology and Therapy

Research, treatment and aesthetic interventions in dermatology

Publishing model:: Open access

Submit your manuscript

Articles

Search all Dermatology and Therapy articles

Filter by

Volume:

Sort by

Date published:

New to old Old to new

Showing 1-50 of 1,180 articles

Consistent Efficacy of Apremilast in Patients with Psoriasis Regardless of Baseline Disease Severity or Special Area Involvement: Subgroup Analysis from PROMINENT
Masatoshi Abe
Yukari Okubo
Ryosuke Hino
Original Research Open access 27 May 2024
Efficacy and Safety of Oxymatrine in the Treatment of Patients with Erythrodermic Psoriasis
Huijuan Shi
Dongmei Chen
Fang Wang
Brief Report Open access 26 May 2024
Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims Data
Andreas Pinter
Ahmed M. Soliman
Mark G. Lebwohl
Original Research Open access 24 May 2024
Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe Itch
José-Manuel Carrascosa
Alessandra Narcisi
Andreas Wollenberg
Original Research Open access 22 May 2024
Biologics Versus JAK Inhibitors. Part I: Cancer Risk. A Narrative Review
Miguel Mansilla-Polo
Daniel Morgado-Carrasco
Review Open access 19 May 2024
A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria
Adam Friedman
Shawn G. Kwatra
Gil Yosipovitch
Review Open access 17 May 2024
Evaluation of the Factors Influencing Mortality in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Study of 166 Patients
Funda Erduran
Esra Adışen
Akın Aktaş
Original Research Open access 17 May 2024
Patient Burden of Nonsegmental Vitiligo: A US Real-World Survey of Dermatologists and Their Patients
David Rosmarin
Jennifer H. Lofland
Jinan Liu
Original Research Open access 16 May 2024
Efficacy and Safety of Crisaborole Ointment 2% in Chinese Patients Aged ≥ 2 Years with Mild to Moderate Atopic Dermatitis
Lin Ma
Xiaohua Tao
Jianzhong Zhang
Original Research Open access 15 May 2024 Pages: 1229 - 1243
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis)
Mario Valenti
Luigi Gargiulo
Alessandra Narcisi
Brief Report Open access 15 May 2024
Anti-aging Effects of Tirbanibulin 1% Ointment: A Real-Life Experience
Federica Li Pomi
Lucia Peterle
Francesco Borgia
Case Series Open access 14 May 2024
Enthesitis and Dactylitis Resolution with Risankizumab for Active Psoriatic Arthritis: Integrated Analysis of the Randomized KEEPsAKE 1 and 2 Trials
Shawn G. Kwatra
Saakshi Khattri
Dennis McGonagle
Original Research Open access 13 May 2024
Effects of 15% Azelaic Acid Gel in the Management of Post-Inflammatory Erythema and Post-Inflammatory Hyperpigmentation in Acne Vulgaris
Huidi Shucheng
Xinyu Zhou
Xian Jiang
Original Research Open access 11 May 2024 Pages: 1293 - 1314
Unmet Needs and Treatment Preference of Systemic Treatments for Moderate-to-Severe Psoriasis from the Perspectives of Patients and Dermatologists in China
Yehong Kuang
Yuzhen Li
Steven Feldman
Original Research Open access 11 May 2024 Pages: 1245 - 1257
Comparison of the Efficacy of Clascoterone, Trifarotene, and Tazarotene for the Treatment of Acne: A Systematic Literature Review and Meta-Analysis
Mahek Shergill
Muhammad Usman Ali
Mohannad Abu-Hilal
Review Open access 11 May 2024 Pages: 1093 - 1102
OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian Setting
Sarah Alulis
Nicoletta Bernardini
Fareen Hassan
Original Research Open access 10 May 2024 Pages: 1273 - 1291
Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study
Andreas Pinter
Ahmed M. Soliman
Mark Lebwohl
Original Research Open access 10 May 2024 Pages: 1259 - 1271
Cutaneous Superficial Basal Cell Carcinoma is a Basal Cell Carcinoma In Situ: Electron Microscopy of a Case Series of Basal Cell Carcinomas
Harsimran Kaur
Karen L. de Mesy Bentley
Bruce R. Smoller
Case Series Open access 09 May 2024 Pages: 1359 - 1366
Brodalumab: 5-Year US Pharmacovigilance Report
Mark G. Lebwohl
John Y. Koo
Abby A. Jacobson
Brief Report Open access 09 May 2024 Pages: 1349 - 1357
Comparative Study on the Duration and Efficacy of Various Botulinum Toxin Type A Injections for Reducing Masseteric Muscle Bite Force and Treating Facial Wrinkles
Surachet Sirisuthivoranunt
Supisara Wongdama
Rungsima Wanitphakdeedecha
Original Research Open access 09 May 2024 Pages: 1315 - 1325
Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis
Leon H. Kircik
Linda Stein Gold
William Philip Werschler
Original Research Open access 09 May 2024 Pages: 1211 - 1227
High Intensity Focused Ultrasound (20 MHz) and Cryotherapy as Therapeutic Options for Granuloma Annulare and Other Inflammatory Skin Conditions
Jacek Calik
Tomasz Zawada
Torsten Bove
Original Research Open access 04 May 2024 Pages: 1189 - 1210
Real-World Clinical, Psychosocial, and Economic Burden of Atopic Dermatitis: Results From the ESSENTIAL AD Multicountry Study
Spyridon Gkalpakiotis
Susanna Kannenberg
Iman Almasry
Original Research Open access 04 May 2024 Pages: 1173 - 1187
Telemedicine in Nail Psoriasis: Validation of a New Tool to Monitor (In-Person, In-Picture, and In-Video) Nail Psoriasis Severity in Patients with Concurrent Onychophagia and Onychotillomania
Alessia Pacifico
Matilde Iorizzo
Giovanni Damiani
Original Research Open access 03 May 2024 Pages: 1161 - 1172
Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis
Eric L. Simpson
Marjolein de Bruin-Weller
Jonathan I. Silverberg
Original Research Open access 03 May 2024 Pages: 1145 - 1160
Topical and Systemic Retinoids in the Management of Hidradenitis Suppurativa: A Comprehensive Literature Review
Elisa Molinelli
Helena Gioacchini
Oriana Simonetti
Review Open access 03 May 2024 Pages: 1079 - 1091
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)
Eric L. Simpson
Vimal H. Prajapati
Jonathan I. Silverberg
Original Research Open access 02 May 2024 Pages: 1127 - 1144
Safety and Effectiveness of Percutaneous Ultrasound-Guided Galvanic Current in Tunnels of Patients with Hidradenitis Suppurativa: A Pilot Study
Alberto Soto-Moreno
Carlos Cuenca-Barrales
Alejandro Molina-Leyva
Original Research Open access 27 April 2024 Pages: 1115 - 1125
When Patient Diversity Informs Formulation: Reimagining Treatment for Seborrheic Dermatitis
Meredith Tyree Polaskey
Heather Woolery-Llloyd
Raj Chovatiya
Commentary Open access 27 April 2024 Pages: 1071 - 1077
Impact of Biologic Therapy on Key Cardiovascular Risk Parameters in a Psoriatic Cohort—a Retrospective Review
Joseph Joseph
Kelvin Truong
Annika Smith
Brief Report Open access 25 April 2024 Pages: 1337 - 1348
Economic Burden of Itch-Related Sleep Loss in Moderate-to-Severe Atopic Dermatitis in the United Kingdom
Evangeline J. Pierce
Russel T. Burge
Yunni Yi
Original Research Open access 23 April 2024 Pages: 1103 - 1114
Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics from PSoHO
Elisabeth Riedl
Andreas Pinter
Christopher Schuster
Brief Report Open access 22 April 2024 Pages: 1327 - 1335
Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60
Alexander Egeberg
Jason E. Hawkes
April Armstrong
Original Research Open access 22 April 2024 Pages: 1007 - 1018
The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016
Sissel Brandt Toft Sørensen
Prethibha George
Vera Ehrenstein
Original Research Open access 16 April 2024 Pages: 993 - 1006
Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
Tiago Torres
Anne Sohrt Petersen
José Manuel Carrascosa
Original Research Open access 13 April 2024 Pages: 983 - 992
Novel Topical Treatments for Itch
Rami H. Mahmoud
Omar Mahmoud
Gil Yosipovitch
Review Open access 13 April 2024 Pages: 829 - 840
Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study
Michela Starace
Francesca Pampaloni
Zoe Apalla
Original Research Open access 10 April 2024 Pages: 953 - 970
Publisher Correction to: Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
Eric L. Simpson
Ben Lockshin
Andrew Korotzer
Publisher Correction Open access 09 April 2024 Pages: 1367 - 1369
Letter to the Editor Regarding: Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study
Ruiyao Hu
Yue Wang
Chen Li
Letter Open access 09 April 2024 Pages: 1063 - 1065
Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities
Luca Potestio
Nello Tommasino
Matteo Megna
Review Open access 09 April 2024 Pages: 841 - 852
Response to: Letter to Editor Regarding “Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study”
A. David Burden
Letter Open access 05 April 2024 Pages: 1067 - 1069
Clinical Characteristics and Therapeutic Aspects of Blaschko Linear Psoriasis
Ling Chen
Yufan Cheng
Zhu Shen
Brief Report Open access 05 April 2024 Pages: 1039 - 1048
Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis
Tina Bhutani
John Koo
J. Gabriel Vasquez
Brief Report Open access 04 April 2024 Pages: 1019 - 1025
Acute Systemic Toxicity Caused by Topical Application of EMLA Cream on a Leg Ulcer: Case Report and Review of Literature
Sarah Marie Hoffmann
Anna Luisa Hartmann
Christoph Mathis Schempp
Case Report Open access 03 April 2024 Pages: 1057 - 1062
Utilising SNP Association Analysis as a Prospective Approach for Personalising Androgenetic Alopecia Treatment
Manuel Pacareu Francès
Laura Vila-Vecilla
Gustavo Torres de Souza
Original Research Open access 31 March 2024 Pages: 971 - 981
Maintenance of Investigator’s Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis
Lawrence F. Eichenfield
Linda F. Stein Gold
Juliana M. Canosa
Original Research Open access 28 March 2024 Pages: 875 - 892
Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study
Ying Li
Chengzhi Lv
Yuling Shi
Original Research Open access 27 March 2024 Pages: 907 - 918
Virtual Learning Decreases the Carbon Footprint of Medical Education
Divya Sharma
Julianne Rizzo
Jenny E. Murase
Original Research Open access 26 March 2024 Pages: 853 - 859
Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies
April Armstrong
Alvaro González-Cantero
Andrew Blauvelt
Original Research Open access 23 March 2024 Pages: 933 - 952
Inconsistent Associations Between Risk Factor Profiles and Adjuvant Radiation Therapy (ART) Treatment in Patients with Cutaneous Squamous Cell Carcinoma and Utility of the 40-Gene Expression Profile to Refine ART Guidance
Brent R. Moody
Aaron S. Farberg
Walton A. Taylor
Original Research Open access 23 March 2024 Pages: 861 - 873

1
2
…
24
Next page